Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Non-Current Deferred Tax Liability (2022 - 2025)

InMed Pharmaceuticals (INM) has 1 years of Non-Current Deferred Tax Liability data on record, last reported at $20000.0 in Q2 2025.

  • For Q2 2025, Non-Current Deferred Tax Liability changed N/A year-over-year to $20000.0; the TTM value through Jun 2025 reached $20000.0, changed N/A, while the annual FY2025 figure was $20000.0, N/A changed from the prior year.
  • Non-Current Deferred Tax Liability reached $20000.0 in Q2 2025 per INM's latest filing.
  • Across five years, Non-Current Deferred Tax Liability topped out at $20000.0 in Q2 2025 and bottomed at $20000.0 in Q2 2025.